Hanmi Pharmaceutical Co., Ltd. - Mar 18, 2025 Form SCHEDULE 13D/A Schedule Report for Aptose Biosciences Inc.

Reporting Manager
Hanmi Pharmaceutical Co., Ltd.
Shares outstanding
2.56M shares
Disclosed Ownership
509K shares
Ownership
19.9%
Form type
SCHEDULE 13D/A
Date filed
3/20/2025, 08:54 PM
Date of event
Mar 18, 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Hanmi Pharmaceutical Co., Ltd. 19.9% 509K 509K 0 /s/ Haegon Shin Haegon Shin, Managing Director, Global Business Division 0001904921